Showing results (1511-1520 of 1,559) with videos related to
Sort By:
Pageof 156
Psychiatry Research|May 31, 2025
Safety and efficacy of Deep TMS for adolescent depression based on large real-world data analysisYiftach Roth, Aron Tendler, Gaby S Pell, et al.Journal of Affective Disorders|March 25, 2026
The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisGuy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.The Journal of Cell Biology|October 14, 2004
A standardized kinesin nomenclatureCarolyn J Lawrence, R Kelly Dawe, Karen R Christie, et al.Nature Biotechnology|November 4, 2000
A T-cell-selective interleukin 2 mutein exhibits potent antitumor activity and is well tolerated in vivoA B Shanafelt, Y Lin, M C Shanafelt, et al.JAMA Network Open|February 13, 2023
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm TrialMatthew D Sims, Sahil Khanna, Paul Feuerstadt, et al.Nature Communications|May 10, 2020
Effect of sequence depth and length in long-read assembly of the maize inbred NC358Shujun Ou, Jianing Liu, Kapeel M Chougule, et al.The Lancet. Infectious Diseases|April 16, 2023
Redefining Clostridioides difficile infection antibiotic response and clinical outcomesAnne J Gonzales-Luna, Andrew M Skinner, Carolyn D Alonso, et al.Infectious Diseases and Therapy|June 28, 2024
Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDIColleen S Kraft, Matthew Sims, Michael Silverman, et al.Nature|November 25, 2021
A multi-scale map of cell structure fusing protein images and interactionsYue Qin, Edward L Huttlin, Casper F Winsnes, et al.Blood|October 20, 2022
Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trialNaval G Daver, Monique Dail, Jacqueline S Garcia, et al.Pageof 156